RightFit Trial Directory

Parkinson's Disease clinical trials in Dallas, TX

13 recruiting parkinson's disease studies with a site in Dallas, TX.

All trials in Dallas, TX · All Parkinson's Disease trials

RecruitingPhase 3NCT06623422

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

Sponsor: Merck Sharp & Dohme LLC

Dallas, TX · Houston, TX · +51 more sites

RecruitingPhase 3NCT06312176

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

Sponsor: Merck Sharp & Dohme LLC

Dallas, TX · +43 more sites

RecruitingPhase 3NCT06841354

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

Sponsor: Merck Sharp & Dohme LLC

Dallas, TX · El Paso, TX · Houston, TX · +36 more sites

RecruitingPhase 3NCT06966700

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Sponsor: Merck Sharp & Dohme LLC

Abilene, TX · Dallas, TX · +61 more sites

RecruitingPhase 3NCT07174310

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

Sponsor: Hoffmann-La Roche

Dallas, TX · Round Rock, TX · +51 more sites

RecruitingPhase 2NCT06680830

A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

Sponsor: Neuron23 Inc.

Dallas, TX · Houston, TX · +42 more sites

RecruitingNot applicableNCT04957095

Motor Network Physiology

Sponsor: University of Texas Southwestern Medical Center

Dallas, TX

RecruitingPhase 2NCT07804615

A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy

Sponsor: Vima Therapeutics

Cypress, TX · Dallas, TX · Round Rock, TX · +26 more sites

RecruitingPhase not listedNCT05539196

A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications

Sponsor: InSightec

Dallas, TX · +3 more sites

RecruitingPhase not listedNCT03872102

Facilitating Diagnostics and Prognostics of Parkinsonian Syndromes Using Neuroimaging

Sponsor: University of Texas Southwestern Medical Center

Dallas, TX

RecruitingNot applicableNCT06489483

Action Regulation Behavioral

Sponsor: University of Texas Southwestern Medical Center

Dallas, TX

RecruitingPhase 4NCT06765668

A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease

Sponsor: Impax Laboratories, LLC

Dallas, TX · Georgetown, TX · Houston, TX · +24 more sites

RecruitingNot applicableNCT05982730

SegwayPD: The Effect of Sensory-augmented Postural Training Using Segway on Motor and Cognitive Function in Individuals With Parkinson's Disease

Sponsor: University of Texas Southwestern Medical Center

Dallas, TX

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.